跳至主要内容
临床试验/CTRI/2024/05/068061
CTRI/2024/05/068061已完成不适用

Role of central venous-arterial pCO2 difference(pCO2 gap) in prediction of clinical outcome and prognosis of patients in septic shock.

Navneet Singh1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2024年6月5日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
101
试验地点
1
主要终点
28 day mortality rate

研究概览

简要总结

A prospective observational study will be conducted in a 17 bedded ICU setup of a Multispecialty, University affiliated hospital. A written and informed consent will be taken from the patients/their next of kin(NOK), meeting the inclusion criteria of the study. ABG and VBG samples will be taken for patients diagnosed to be in septic shock, through central venous catheter and arterial catheter respectively. The samples will be taken at T= 0 Hrs and T= 6 Hrs, where T0 is the time at which the patient was started on vasopressor support.

PCO2 gap found (the worse value among T0 and T6) will be considered and correlated with 28 day mortality rates of the patients.

Similarly PCO2 values will also be correlated with : Serum Lactate levels, SOFA score and Length of stay in ICU

Positive correlation will be considered if there are higher 28 day mortality rates with 𝛥PCO2 > 6mmHg.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • Adult patients admitted as a case of Septic Shock with Vasopressor requirement to maintain Mean Arterial Pressure greater than 65mmHg, Serum Lactate level above 2mmol/L and without any hypovolemia.

排除标准

  • Pregnancy, age below 18yrs, patients with end stage neoplasms, and patients suffering from lung diseases.

结局指标

主要结局

28 day mortality rate

时间窗: 28 days

次要结局

  • Length of stay in ICU, SOFA score, and Serum Lactate levels(28 days)

研究者

发起方
Navneet Singh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Navneet Singh

Command Hospital Air Force Bangalore

研究点 (1)

Loading locations...

相似试验

Role of pCO2 gap in prediction of clinical outcome... | 临床试验